BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dawidowski B, Górniak A, Podwalski P, Lebiecka Z, Misiak B, Samochowiec J. The Role of Cytokines in the Pathogenesis of Schizophrenia. J Clin Med 2021;10:3849. [PMID: 34501305 DOI: 10.3390/jcm10173849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shnayder NA, Khasanova AK, Strelnik AI, Al-zamil M, Otmakhov AP, Neznanov NG, Shipulin GA, Petrova MM, Garganeeva NP, Nasyrova RF. Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia. IJMS 2022;23:11324. [DOI: 10.3390/ijms231911324] [Reference Citation Analysis]
2 Chamera K, Curzytek K, Kamińska K, Trojan E, Basta-kaim A. Quetiapine Ameliorates MIA-Induced Impairment of Sensorimotor Gating: Focus on Neuron-Microglia Communication and the Inflammatory Response in the Frontal Cortex of Adult Offspring of Wistar Rats. Cells 2022;11:2788. [DOI: 10.3390/cells11182788] [Reference Citation Analysis]
3 Wang X, Xiu M, Wang K, Su X, Li X, Wu F. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia. Metabolomics 2022;18:50. [PMID: 35819637 DOI: 10.1007/s11306-022-01909-4] [Reference Citation Analysis]
4 Cheng Y, Wang T, Zhang T, Yi S, Zhao S, Li N, Yang Y, Zhang F, Xu L, Shan B, Xu X, Xu J. Increased blood-brain barrier permeability of the thalamus and the correlation with symptom severity and brain volume alterations in schizophrenia patients. Biol Psychiatry Cogn Neurosci Neuroimaging 2022:S2451-9022(22)00150-1. [PMID: 35738480 DOI: 10.1016/j.bpsc.2022.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khan MM. Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia. World J Psychiatry 2022; 12(6): 827-842 [DOI: 10.5498/wjp.v12.i6.827] [Reference Citation Analysis]
6 Ma H, Cheng N, Zhang C. Schizophrenia and Alarmins. Medicina (Kaunas) 2022;58:694. [PMID: 35743957 DOI: 10.3390/medicina58060694] [Reference Citation Analysis]
7 Daniel WA, Bromek E, Danek PJ, Haduch A. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions. Biochem Pharmacol 2022;199:115006. [PMID: 35314167 DOI: 10.1016/j.bcp.2022.115006] [Reference Citation Analysis]
8 Martin S, Foulon A, El Hage W, Dufour-Rainfray D, Denis F. Is There a Link between Oropharyngeal Microbiome and Schizophrenia? A Narrative Review. Int J Mol Sci 2022;23:846. [PMID: 35055031 DOI: 10.3390/ijms23020846] [Reference Citation Analysis]
9 Waszkiewicz N. Ordering Knowledge in the Markers of Psychiatric/Mental Disorders. J Clin Med 2022;11:284. [PMID: 35053980 DOI: 10.3390/jcm11020284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-mazur J, Mak M, Rek-owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110510] [Reference Citation Analysis]
11 Löscher W, Kaila K. CNS pharmacology of NKCC1 inhibitors. Neuropharmacology 2021;:108910. [PMID: 34883135 DOI: 10.1016/j.neuropharm.2021.108910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Łoś K, Kulikowska J, Waszkiewicz N. First-Time Psychotic Symptoms in a Patient After COVID-19 Infection-A Case Report. Front Psychiatry 2021;12:726059. [PMID: 34721104 DOI: 10.3389/fpsyt.2021.726059] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Kverno K. Brain Fog: A Bit of Clarity Regarding Etiology, Prognosis, and Treatment. J Psychosoc Nurs Ment Health Serv 2021;59:9-13. [PMID: 34714198 DOI: 10.3928/02793695-20211013-01] [Reference Citation Analysis]